Carol Worrell

1.5k citations

19 papers · 974 indexed · h-index 16

Co-authors: Rohan Hazra Steven L. Zeichner Antonella N. Tullio John F. Flaherty Brian P. Kearney Kitty Yale Ellen S. DeCarlo Craig M. Wilson
Topics: HIV/AIDS drug development and treatment (10 papers)HIV Research and Treatment (8 papers)HIV/AIDS Research and Interventions (7 papers)
Cited by: Virology Emergency Medicine Infectious Diseases
Journals: PEDIATRICS Clinical Infectious Diseases Antimicrobial Agents and Chemotherapy
Partner nations: United States France South Africa

In The Last Decade

Carol Worrell

19 papers receiving 945 citations

Peers

Countries citing papers authored by Carol Worrell

Since Specialization

Citations

This map shows the geographic impact of Carol Worrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Worrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Worrell more than expected).

Fields of papers citing papers by Carol Worrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Worrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Worrell. The network helps show where Carol Worrell may publish in the future.

Co-authorship network of co-authors of Carol Worrell

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Worrell. A scholar is included among the top collaborators of Carol Worrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Worrell. Carol Worrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection 2017 ·AIDS ·Carolyn Bolton‐Moore,Edmund V. Capparelli,Pearl Samson,Mutsa Bwakura‐Dangarembizi,Patrick Jean‐Philippe,Carol Worrell,Barbara Heckman,Lynette Purdue,Stephen A. Spector,(unknown),William Borkowsky,Amy James Loftis,Elizabeth Hawkins,Carole L. Wallis,Ellen G. Chadwick	17
2	Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age 2015 ·The Journal of Clinical Pharmacology ·Matthew L. Rizk,Lihong Du,(unknown),Larissa Wenning,Hedy Teppler,(unknown),Bobbie Graham,(unknown),Sharon Nachman,Andrew Wiznia,Carol Worrell,Betsy Smith,Edward P. Acosta	13
3	Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update 2015 ·Clinical Infectious Diseases ·Stephen M. Graham,Luís E. Cuevas,Patrick Jean‐Philippe,Renee Browning,Martina Casenghi,Anne Detjen,Devasena Gnanashanmugam,Anneke C. Hesseling,Beate Kampmann,Anna M. Mandalakas,Ben J. Marais,Marco Schito,Hans Spiegel,Jeffrey R. Starke,Carol Worrell,Heather J. Zar	205
4	Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Larry K. Brown,Betsy D. Kennard,Graham J. Emslie,Taryn L. Mayes,Laura Whiteley,James Bethel,Jiahong Xu,Sarah Thornton,Mary Tanney,Linda Hawkins,Patricia A. Garvie,Geetha Subramaniam,Carol Worrell,(unknown)	29
5	A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis: Table 1. 2015 ·Clinical Infectious Diseases ·Mark P. Nicol,Devasena Gnanashanmugam,Renee Browning,Eleanor S. Click,Luís E. Cuevas,Anne Detjen,Stephen M. Graham,Michael Levin,Mamodikoe Makhene,Payam Nahid,Carlos M. Pérez‐Vélez,Klaus Reither,Rinn Song,Hans Spiegel,Carol Worrell,Heather J. Zar,Gerhard Walzl	22
6	Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Bret J. Rudy,Bill G. Kapogiannis,Carol Worrell,Kathleen Squires,James Bethel,Sam Li,Craig M. Wilson,Allison L. Agwu,Patricia Emmanuel,(unknown),(unknown),Maureen M. Goodenow,John W. Sleasman	24
7	Tuberculosis in HIV-infected infants, children, and adolescents in Latin America 2014 ·The Brazilian Journal of Infectious Diseases ·Margot R. Krauss,D.R. Harris,Thalita Fernandes de Abreu,(unknown),(unknown),Carol Worrell,Rohan Hazra	13
8	Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women 2013 ·Clinical Infectious Diseases ·Jessica A. Kahn,Jiahong Xu,Bill G. Kapogiannis,Bret J. Rudy,René Gonin,Nancy Liu,Craig M. Wilson,Carol Worrell,Kathleen Squires	82
9	Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jessica A. Kahn,Robert D. Burk,Kathleen Squires,Bill G. Kapogiannis,Bret J. Rudy,Jiahong Xu,René Gonin,Nancy Liu,Carol Worrell,Craig M. Wilson	15
10	Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Patricia M. Flynn,Coleen K. Cunningham,Bret J. Rudy,Craig M. Wilson,Bill G. Kapogiannis,Carol Worrell,James Bethel,Dina Monte,Kelly Bojan	36
11	Factors Associated with Insulin Resistance among Children and Adolescents Perinatally Infected with HIV-1 in the Pediatric HIV/AIDS Cohort Study 2011 ·Hormone Research in Paediatrics ·Mitchell E. Geffner,Kunjal Patel,Tracie L. Miller,Rohan Hazra,Margarita Silió,Russell B. Van Dyke,William Borkowsky,Carol Worrell,Linda A. DiMeglio,Denise L. Jacobson,(unknown)	58
12	Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood 2010 ·Metabolism ·(unknown),V Thomas,Anna M. Cushing,Julia Purdy,Carol Worrell,Jeffrey B. Kopp,Rohan Hazra,Colleen Hadigan	38
13	Obesity and Dyslipidemia in Behaviorally HIV‐Infected Young Women: Adolescent Trials Network Study 021 2009 ·Clinical Infectious Diseases ·Kathleen Mulligan,D.R. Harris,Dina Monte,Sonia Stoszek,Patricia Emmanuel,Dana S. Hardin,Bill G. Kapogiannis,Carol Worrell,William A. Meyer,John W. Sleasman,Craig M. Wilson,Grace M. Aldrovandi	29
14	Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors 2008 ·Antimicrobial Agents and Chemotherapy ·Brian L. Robbins,Edmund V. Capparelli,Ellen G. Chadwick,Ram Yogev,Leslie Serchuck,Carol Worrell,Mary E. Smith,Carmelita Alvero,Terence Fenton,Barbara Heckman,Stephen I. Pelton,Grace M. Aldrovandi,William Borkowsky,Jack Rodman,Peter L. Havens	22
15	Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected Children 2006 ·PEDIATRICS ·Rachel I. Gafni,Rohan Hazra,James C. Reynolds,Frank Maldarelli,Antonella N. Tullio,Ellen S. DeCarlo,Carol Worrell,John F. Flaherty,Kitty Yale,Brian P. Kearney,Steven L. Zeichner	133
16	Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy for Pediatric HIV Infection 2005 ·PEDIATRICS ·Rohan Hazra,Rachel I. Gafni,Frank Maldarelli,Frank M. Balis,Antonella N. Tullio,Ellen S. DeCarlo,Carol Worrell,Seth M. Steinberg,John F. Flaherty,Kitty Yale,Brian P. Kearney,Steven L. Zeichner	72
17	Natural History of Lipid Abnormalities and Fat Redistribution Among Human Immunodeficiency Virus-Infected Children Receiving Long-Term, Protease Inhibitor-Containing, Highly Active Antiretroviral Therapy Regimens 2004 ·PEDIATRICS ·(unknown),Carol Worrell,Seth M. Steinberg,Rohan Hazra,Shirley Jankelevich,Lauren V. Wood,Sheryl Zwerski,Robert Yarchoan,Steven L. Zeichner	66
18	Single-Dose and Steady-State Pharmacokinetics of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Children 2003 ·Antimicrobial Agents and Chemotherapy ·Rohan Hazra,Frank M. Balis,Antonella N. Tullio,Ellen S. DeCarlo,Carol Worrell,Seth M. Steinberg,John F. Flaherty,Kitty Yale,(unknown),Brian P. Kearney,Lijie Zhong,Dion F. Coakley,Stéphane Blanche,Jean Bresson,(unknown),Steven L. Zeichner	44
19	Ganciclovir Treatment of Gastrointestinal Infections Caused by Cytomegalovirus in Patients with AIDS 1988 ·Clinical Infectious Diseases ·Douglas T. Dieterich,Abraham Chachoua,(unknown),Carol Worrell	56

About Carol Worrell

Carol Worrell is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 19 papers that have together received 974 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). The work is most often cited by research in Virology (217 citations), Emergency Medicine (323 citations) and Infectious Diseases (613 citations). Carol Worrell has collaborated with scholars based in United States, France and South Africa. Frequent co-authors include Rohan Hazra, Steven L. Zeichner, Antonella N. Tullio, John F. Flaherty, Brian P. Kearney, Kitty Yale, Ellen S. DeCarlo, Craig M. Wilson, Bill G. Kapogiannis and Rachel I. Gafni. Their work appears in journals such as PEDIATRICS, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact